{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:34:45Z","timestamp":1768552485561,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ijrobp.2015.02.008","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T02:02:10Z","timestamp":1428544930000},"page":"40-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Expert Radiation Oncologist Interpretations of Involved-Site Radiation Therapy Guidelines in the Management of Hodgkin Lymphoma"],"prefix":"10.1016","volume":"92","author":[{"given":"Bradford S.","family":"Hoppe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard T.","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2015.02.008_bib1","first-page":"1232","article-title":"Prophylactic treatment of adjacent areas in Hodgkin's disease","volume":"26","author":"Peters","year":"1966","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2015.02.008_bib2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1148\/78.4.553","article-title":"The radical radiotherapy of regionally localized Hodgkin's disease","volume":"78","author":"Kaplan","year":"1962","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2015.02.008_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0360-3016(85)90357-8","article-title":"The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984","volume":"11","author":"Rosenberg","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"suppl 2","key":"10.1016\/j.ijrobp.2015.02.008_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/annonc\/5.suppl_2.S107","article-title":"Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early-stage Hodgkin's disease. EORTC Lymphoma Cooperative Group. Groupe Pierre-et-Marie-Curie","volume":"5","author":"Noordijk","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.008_bib5","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1200\/JCO.2003.03.023","volume":"21","author":"Engert","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.008_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM199807023390104","article-title":"Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma","volume":"339","author":"Miller","year":"1998","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1016\/j.ijrobp.2015.02.008_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/annonc\/13.S1.79","article-title":"The involved field is back: Issues in delineating the radiation field in Hodgkin's disease","volume":"13","author":"Yahalom","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.008_bib8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.radonc.2006.05.015","article-title":"Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines","volume":"79","author":"Girinsky","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.008_bib9","unstructured":"ICRU. International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photon therapy. (Supplement to ICRU Report 50). |ICRU Report 62. 1999."},{"key":"10.1016\/j.ijrobp.2015.02.008_bib10","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ijrobp.2012.08.041","article-title":"Involved node radiation therapy: an effective alternative in early-stage hodgkin lymphoma","volume":"85","author":"Maraldo","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.02.008_bib11","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ijrobp.2013.05.005","article-title":"Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG)","volume":"89","author":"Specht","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.02.008_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.prro.2014.05.003","article-title":"Implementation of contemporary radiation therapy planning concepts for pediatric Hodgkin lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group","volume":"5","author":"Hodgson","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.008_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijrobp.2014.01.006","article-title":"Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"89","author":"Illidge","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.02.008_bib14","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1200\/JCO.2004.12.170","article-title":"ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: Long-term results","volume":"22","author":"Bonadonna","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.008_bib15","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1093\/annonc\/mds110","article-title":"Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphoma","volume":"23","author":"Sasse","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.008_bib16","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ijrobp.2014.04.029","article-title":"Involved-node proton therapy in combined modality therapy for hodgkin lymphoma: Results of a phase 2 study","volume":"89","author":"Hoppe","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.02.008_bib17","unstructured":"International Commission on Radiation Units and Measurements. [website] 2014. Available at: http:\/\/www.icru.org\/. Accessed February 22,\u00a02015."},{"key":"10.1016\/j.ijrobp.2015.02.008_bib18","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.ijrobp.2007.12.002","article-title":"Quality control of involved field radiotherapy in patients with early-favorable (HD10) and early-unfavorable (HD11) Hodgkin's lymphoma: an analysis of the German Hodgkin Study Group","volume":"71","author":"Eich","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301615001704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301615001704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T19:51:23Z","timestamp":1537732283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301615001704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0360301615001704"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2015.02.008","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expert Radiation Oncologist Interpretations of Involved-Site Radiation Therapy Guidelines in the Management of Hodgkin Lymphoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2015.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}